The publication of this content was sponsored by Deciphera Pharmaceuticals, LLC.
Gastrointestinal stromal tumours (GIST) are rare and complex and require specialised management to ensure optimal patient outcomes.1 Insights from experts in the field underscore the critical role of collaboration with Sarcoma Centres in delivering comprehensive care for GIST patients.
These expert opinions highlight the necessity of integrating expert consultation into the patient journey to improve treatment efficacy and patient well-being.
Taking the example of Germany, where the healthcare system allows for a decentralised approach to GIST treatment, Peter Reichardt emphasises the importance of early expert consultation:
This collaborative approach ensures that patients benefit from the expertise of specialised centres while allowing flexibility in treatment settings.
The value of multidisciplinary collaboration is further emphasised by Bruno Vincenzi, highlighting that in Sarcoma Centres, multidisciplinary tumour boards play a pivotal role in patient management:
These boards facilitate the exchange of knowledge and experiences among oncologists, pathologists, and surgeons, leading to more informed decision-making and improved patient care.
The insights from these experts underscore the significance of collaborating with Sarcoma Centres to provide the best possible care for GIST patients. By integrating expert consultation and multidisciplinary collaboration into the treatment pathway, healthcare providers can ensure that patients receive comprehensive and personalised care, ultimately leading to improved outcomes.1
Experts:
Peter Reichardt1
Bruno Vincenzi2
1. Professor of Oncology, Chief Physician Oncology and Palliative Medicine and Head of the Sarcoma Centre Berlin-Brandenburg, HELIOS Klinikum Berlin-Buch GmbH, Berlin, Germany
2. Professor of Medical Oncology, Head of the Oncology DH Unit, Fondazione Policlinico Universitario, Campus Bio-Medico, Rome, Italy
DCPH-P02226 | June 2025
References
1. Casali PG et al. Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2022;33(1):20-33
